Athenex Inc

NASDAQ:ATNX   3:58:41 PM EDT
0.41
-0.01 (-2.48%)
Debt Financing / Related, Divestitures / Spin-offs

Athenex Announces Sale Of Revenues From U.S. And European Royalty And Milestone Interests In Klisyri® (Tirbanibulin) To Sagard Healthcare Partners And Oaktree

Published: 06/22/2022 14:50 GMT
Athenex Inc (ATNX) - Athenex Announces Sale of Revenues From U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree.
Athenex Inc - Total Transaction Value of $85 Million; at Least $80 Million to Be Used Toward Debt Paydown and to Fund Operations.
Athenex - Sale of Revenues From U.S. and European Royalty in Klisyri to Sagard Healthcare Partners & Funds Managed by Oaktree Capital Management.